Submit Deal

Submit Deal

Cover Image Kevin Bitterman

Kevin Bitterman

Partner at ATLAS VENTURE LP

Investor

Deal Bio

Total Deals8

Valued Deals8

Total Value£ 1.01 B

Avg. Deal Size£ 127 M

Market Context

Sort

24 Jul 2020|China|Biotechnology

Target: HAIHE BIOPHARMA

Bidder: CHAOS INVESTMENT

10 Service Providers

2 Target | 8 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 134 M

Value

05 Jan 2021|United States|Biotechnology

Target: IKENA ONCOLOGY

Bidder: OMEGA FUNDS

15 Service Providers

3 Target | 12 Bidder

15 Dealmakers

3 Target | 12 Bidder

£ 88 M

Value

17 Nov 2021|United States|Biotechnology

Target: CHROMA MEDICINE

Bidder: ATLAS VENTURE LP

10 Service Providers

1 Target | 9 Bidder

12 Dealmakers

3 Target | 9 Bidder

£ 93 M

Value

05 Jan 2022|United States|Biotechnology

Target: KORRO BIO

Bidder: ATLAS VENTURE LP

13 Service Providers

2 Target | 11 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 85 M

Value

19 Jul 2024|United States|Biotechnology

Target: GRO BIOSCIENCES

Bidder: ATLAS VENTURE LP

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 46 M

Value

07 Oct 2024|United States|Biotechnology

Target: JUDO BIO

Bidder: ATLAS VENTURE LP

4 Service Providers

3 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 76 M

Value

10 Jul 2025|United States|Biotechnology

Target: RENASANT BIO

Bidder: ATLAS VENTURE LP

7 Service Providers

3 Target | 4 Bidder

11 Dealmakers

7 Target | 4 Bidder

£ 40 M

Value

14 Oct 2025|United States|Pharmaceuticals

Target: KAILERA THERAPEUTICS

Bidder: ROYALTY PHARMA

16 Service Providers

1 Target | 15 Bidder

32 Dealmakers

2 Target | 30 Bidder

£ 449 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Kevin Bitterman